PRAXIS PRECISION MEDICINES, INC. (PRAX) Return on equity 2022–2025
PRAXIS PRECISION MEDICINES, INC. (PRAX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-34.5%FY2025 · since FY2022: -281.2% → -34.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34.5% | +6.5 pp |
| FY2024 | -41.0% | +135.9 pp |
| FY2023 | -176.9% | +104.3 pp |
| FY2022 | -281.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PRAX financial trends
PRAX RevenuePRAX Net incomePRAX Net marginPRAX Gross profitPRAX Gross marginPRAX Operating incomePRAX Operating marginPRAX Operating cash flowPRAX Free cash flowPRAX Capital expendituresPRAX Stock buybacksPRAX Dividends paidPRAX Total assetsPRAX Total liabilitiesPRAX Shareholders’ equityPRAX overview →